Here’s what you should know.
1. Physicians treated the first patients with TruDi at two U.S.-based healthcare facilities April 16.
2. The TruDi system is an electromagnetic image-guided system ENT Surgeons can use for endoscopic sinus surgeries and for both intranasal and paranasal image-guided navigation procedures.
3. The system also allows for the use of Relieva Spinplus Nav, the first 3-D navigation-enabled balloon sinuplasty system.
4. Acclarent developed TruDi with Biosense Webster’s advanced imaging systems.
Johnson & Johnson Medical Devices Cardiovascular & Specialty Solutions Company Group Chair Shlomi Nachman said, “With the launch of TruDi, Acclarent builds on its legacy of pioneering minimally invasive treatment options for patients suffering from chronic sinusitis and eustachian tube dysfunction. We’re extremely proud of this advancement and the potential it has to transform ENT procedures.”
More articles on supply chain:
125k procedures in 30 years: HCA’s Surgery Center of Rome celebrates anniversary
Gateway Ambulatory Surgery Center secures $87k equity financing
Compass Surgical Partners, Martin Health open GI ASC: 4 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.